Quoin Pharmaceuticals, Ltd. - American Depositary Shares (NQ:QNRX)

4.470 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quoin Pharmaceuticals, Ltd. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 05, 2024

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 05, 2024

Via Benzinga

Preview: Quoin Pharmaceuticals's Earnings ↗

November 07, 2023

Via Benzinga

Asensus Surgical Continues to Spearhead Innovations and Growth in Surgical Robotics

August 17, 2023

From PCG Digital

Via ACN Newswire

Nasdaq Down 250 Points; ISM Services PMI Falls In February ↗

March 05, 2024

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 250 points on Tuesday. The Dow traded down 0.64% to 38,741.00 while the NASDAQ fell 1.64% to 15,942.27. The...

Via Benzinga

Topics Stocks

Why Quoin Pharmaceuticals (QNRX) Shares Are Nosediving ↗

March 05, 2024

Quoin Pharmaceuticals shares are trading lower by 46.9% Tuesday morning. The company announced the pricing of a $6.5 million public offering.

Via Benzinga

Dow Dips Over 100 Points; Target Posts Upbeat Earnings ↗

March 05, 2024

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.33% to 38,861.95 while the NASDAQ...

Via Benzinga

Topics Stocks

TSLA Stock Alert: Tesla Plunges on Major China Slowdown ↗

March 05, 2024

Tesla stock is falling on Tuesday as TSLA investors digest the latest delivery data from the EV company and a decrease in China.

Via InvestorPlace

Why Is GitLab (GTLB) Stock Down 22% Today? ↗

March 05, 2024

GitLab stock is falling hard on Tuesday as investors in GTLB react to a lackluster guidance in the company's Q4 earnings report.

Via InvestorPlace

Why Is Quoin Pharmaceuticals (QNRX) Stock Down 50% Today? ↗

March 05, 2024

Quoin Pharmaceuticals stock is falling on Tuesday after the company announced the pricing of QNRX shares in a public offering.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 05, 2024

Via Benzinga

Why Paymentus Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

March 05, 2024

Shares of Paymentus Holdings, Inc. (NYSE: PAY) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth quarter financial results.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 05, 2024

It's time to start off trading this morning with a breakdown of the biggest pre-market stock movers worth watching on Tuesday!

Via InvestorPlace

Crude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike Higher ↗

March 04, 2024

U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday. The Dow traded down 0.20% to 39,007.30 while the NASDAQ fell 0.18% to 16,245.77. The S&P 500 also fell,...

Via Benzinga

Topics Stocks

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 04, 2024

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its...

Via Benzinga

Gold Gains 1%; JOANN Shares Plummet ↗

March 04, 2024

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 0.2% on Monday. The Dow traded down 0.25% to 38,988.86 while the NASDAQ fell 0.18% to 16,245.30. The S&P 500...

Via Benzinga

Topics Stocks

Why Quoin Pharmaceutical Stock Is Soaring ↗

March 04, 2024

Quoin announced clearance from the U.S. Food and Drug Administration (FDA) to recruit teen subjects aged 14 years and older into its two ongoing clinical trials for QRX003, which is being developed as...

Via Benzinga

Dow Falls Over 100 Points; Sea Posts Upbeat Sales ↗

March 04, 2024

U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market opening Monday, the Dow traded down 0.34% to 38,951.34 while the NASDAQ fell...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 04, 2024

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

February 12, 2024

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

February 05, 2024

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

January 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 30, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 29, 2023

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

November 13, 2023

Via Benzinga

REPEAT -- Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome

October 24, 2023

From Quoin Pharmaceuticals, Inc.

Via GlobeNewswire

5 Value Stocks In The Healthcare Sector ↗

October 09, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 29, 2023

Friday's session saw 112 companies set new 52-week lows.

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

August 28, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.